Posters

      Systems Toxicology Assessment of Repeated Exposure to Cigarette Smoke and a Candidate Modified-Risk Tobacco Product Aerosol on Gingival Organotypic Cultures

      Zanetti, F.; Sewer, A.; Leroy, P.; Majeed, S.; Ortega Torres, L.; Merg, C.; Corciulo, M.; Trivedi, K.; Guedj, E.; Elamin, A.; Frentzel, S.; Ivanov, N. V.; Peitsch, M. C.; Hoeng, J.

      Conference date
      Sep 13, 2017
      Conference name
      EUROTOX 2017
      Link to more information
      Topic
      Summary

      No abstract available.

      Related Publications

      Selected Aldehydes Yields in the Aerosol of Commercial Electronic Cigarettes

      Aerosol Chemistry

      Quantitation of Selected Elements in the Aerosol of Electrically Heated Tobacco Products (eHTPs) by Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

      Aerosol Chemistry

      Heating vs. Burning: A Non-Targeted Analytical Characterization of Compounds with Higher Abundance in the Aerosol of a Heated Tobacco Product than in Mainstream Cigarette Smoke

      Aerosol Chemistry

      Statistical Derivation of a Fold-Change Cut-Off for Non-Targeted Differential Screening Studies Based on Analytical Method Variability

      Aerosol Chemistry

      Pitfalls in the Detection of Volatiles Associated with Heated Tobacco and e-Vapor Products When Using PTR-TOF-MS

      Aerosol Chemistry

      Non-targeted analytical comparison of a heated tobacco product aerosol against mainstream cigarette smoke: does heating tobacco produce an inherently different set of aerosol constituents?

      Aerosol Chemistry

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.